Open tenders for Novo Nordisk
60 open tenders fit what Novo Nordisk offers; 20+ come from public bodies that already sign contracts with Novo Nordisk.
Tenders that fit what Novo Nordisk offers
Closest in meaning to its products: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders · Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders. Tenders in other languages match too. Best fit first, top 20 of 60.
Open House Biologika Rabattverträge 2025-11 - Insulin, normal (human)
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Open-House-Biologika-Rabattverträge 2025-26 - Insulin lispro (ATC: A10AB04, Wirkstärke: 100 U/ml)
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Suministro de equipos de sistemas de infusión de insulina subcutánea o sistemas de asa cerrada híbridos, para pacientes con diabetes mellitus tipo 1 para los servicios de Endocrinología y Pediatría
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Open House Biologika Rabattverträge 2025-13 - Insulin-isophan/Insulin, normal (human) (Wirkstoffkombination)
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Open-House-Biologika-Rabattverträge 2025-18 - Insulin glargin (Wirkstärke: 100 U/ml)
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Glukoosimittarit ja niiden tarvikkeet omaseurantaan
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Open House Biologika Rabattverträge 2025-12 - Insulin-isophan (human)
Fits: Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders
Procedura aperta per la conclusione di accordi quadro, volti all’affidamento della fornitura in service di microinfusori per insulina, sistemi di monitoraggio, sensori, servizi connessi e relativo mat
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Insulinpumpar, CGM och flergångspennor
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Insulin lispro, ATC A10AB04 und A10AD04 für die Zeit 01.01.2026 - 31.12.2027
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Furnizare consumabile de diabet
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Liraglutid (ATC-Code: A10BJ02).
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Open-House-Biologika-Rabattverträge 2026-10 - Infliximab (Darreichungsform zur subkutanen Injektion)
Fits: Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders
Open-House-Biologika-Rabattverträge 2025-08 - Denosumab
Fits: Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders
Dostawa leku do badania klinicznego (Tirzepatyd)
Fits: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders
Open-House-Biologika-Rabattverträge 2025-36 - Natalizumab (Darreichungsform zur subkutanen Injektion)
Fits: Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders
Open-House-Biologika-Rabattverträge 2025-31 - Denosumab
Fits: Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders
Open House Biologika Rabattverträge 2026 - 19 - Denosumab (Wirkstärke 60mg)
Fits: Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders
Open-House-Biologika-Rabattverträge 2025-01 - Infliximab
Fits: Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders
Open House Biologika Rabattverträge 2026-23 - Darbepoetin alfa
Fits: Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders
Your public customers are buying
Open tenders from buyers that signed contracts with Novo Nordisk in the last two years (Slovak and Czech contract registers). Everything they tender, not only what Novo Nordisk sells.
LP s obsahem relugolixu 2026 - sdružený nákup
Perorální Cytostatikum s obsahovou látkou Belzutifanum
Léčivé přípravky s obsahem ruxolitinibu - Sdružený nákup 2026
Zajištění dodavatele reklamních předmětů a poskytovatele tiskařských služeb
„Úklidové služby v objektu Psychiatrie pavilon X“
Léčivé přípravky s obsahem injekčních forem glukokortikoidů 2026
Navigační systém pro ORL vč. spotřebního materiálu
Endoskopické věže pro GEHO
Léčivý přípravek s účinnou látkou OSIMERTINIB-MESILÁT
Léčivý přípravek s účinnou látkou IPILIMUMAB
Servisní služby na produkty výrobce Siemens II
Sterilní svářečka hadiček odběrových setů - stolní s průběžnými dodávkami spotřebního materiálu
LP s obsahem vandetanibu 2026
Nefrostomický katetr a punkční set
Roztok aditivní pro skladování trombocytů
Léčivé přípravky s obsahem ketaminu, lidokainu
Léčivé přípravky s obsahem everolimusu - Sdružený nákup 2026
Servisní služby na produkty výrobce R. Wolf, Erbe
Ultrazvukový diagnostický systém pro neurologickou cévní diagnostiku
Dodávky LP - společný nákup